Campath
Showing 26 - 50 of 263
Lymphoma, Leukemia Trial in Houston (drug, other, radiation, procedure)
T-Cell Lymphoma Relapsed, Adult T-Cell Leukemia (ATL), Peripheral T-Cell Lymphoma (PTCL) Trial run by the NCI (IL-15 plus,
Completed
- T-Cell Lymphoma Relapsed
- +4 more
- IL-15 plus
- alemtuzumab
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 27, 2022
Systemic Sclerosis, Diffuse Sclerosis Systemic, Interstitial Lung Disease Trial in Pittsburgh (Cyclophosphamide, Mesna,
Recruiting
- Systemic Sclerosis
- +3 more
- Cyclophosphamide
- +8 more
-
Pittsburgh, Pennsylvania
- +2 more
Dec 17, 2021
Leukemia, Erythroblastic, Acute, MDS Trial in New York (5-Azacytidine, Fludarabine, Melphalan)
Completed
- Leukemia, Erythroblastic, Acute
- Myelodysplastic Syndromes
- 5-Azacytidine
- +4 more
-
New York, New YorkWeill Cornell Medical College
Aug 25, 2021
Sickle Cell Disease, Beta Thalassemia Trial in New York (Busulfan, Fludarabine, Alemtuzumab)
Active, not recruiting
- Sickle Cell Disease
- Beta Thalassemia
- Busulfan
- +3 more
-
New York, New YorkMorgan Stanley Children's Hospital, New York-Presbyterian, Colum
Aug 12, 2021
Leukemia Trial in Chicago (Alemtuzumab, Rituximab)
Completed
- Leukemia
- Alemtuzumab
- Rituximab
-
Chicago, IllinoisNorthwestern University, Northwestern Medical Faculty Foundation
Oct 15, 2020
Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia Trial in
Active, not recruiting
- Stage I Chronic Lymphocytic Leukemia
- +3 more
- alemtuzumab
- +2 more
-
Chicago, Illinois
- +1 more
Dec 29, 2020
Acute Undifferentiated Leukemia, B-cell Adult Acute Lymphoblastic Leukemia, B-cell Childhood Acute Lymphoblastic Leukemia Trial
Completed
- Acute Undifferentiated Leukemia
- +13 more
- allopurinol
- +16 more
-
Chicago, IllinoisCancer and Leukemia Group B
Apr 5, 2022
Sickle Cell Disease, Stem Cell Transplant Complications, Red Blood Cell Disorder Trial in Calgary (Alemtuzumab, Total Body
Recruiting
- Sickle Cell Disease
- +3 more
- Alemtuzumab
- +2 more
-
Calgary, Alberta, CanadaAlberta Children's Hospital
May 25, 2021
Severe Aplastic Anemia, Refractory, Severe Aplastic Anemia, Relapse Trial run by the NHLBI (Alemtuzumab (Campath ),
Completed
- Severe Aplastic Anemia, Refractory
- Severe Aplastic Anemia, Relapse
- Alemtuzumab (Campath )
- Cyclosporine
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 29, 2020
Renal Transplantation Trial in United States (Alemtuzumab, rabbit antithymocyte globulin, Belatacept)
Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma Trial in New York (Bendamustine, Carmustine, Etoposide)
Completed
- Hodgkin's Lymphoma
- Non-Hodgkin's Lymphoma
- Bendamustine
- +8 more
-
New York, New YorkWeill Cornell Medical College
Feb 1, 2021
Ewing Sarcoma, Gastrointestinal Tumor, Germ Cell Tumor Trial in Memphis (drug, biological, device)
Completed
- Ewing Sarcoma
- +12 more
- alemtuzumab
- +6 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Oct 14, 2020
Immunosuppression, Kidney Transplantation, Graft Rejection Trial in Chicago (Infusion of Donor Hematopoietic Stem Cells and
Active, not recruiting
- Immunosuppression
- +2 more
- Infusion of Donor Hematopoietic Stem Cells and Campath-1H
-
Chicago, IllinoisNorthwestern Memorial Hospital
May 22, 2020
Metabolic Disorders, Hematologic, Immune, or Bone Marrow Disorders, Hemoglobinopathies Trial in Canada, United States (Treatment
Recruiting
- Metabolic Disorders
- +3 more
- Treatment Plan 1: Stratum 1
- +3 more
-
Phoenix, Arizona
- +19 more
Oct 12, 2021
Mycosis Fungoides, Sezary Syndrome Trial run by the NHLBI (A matched peripheral donor stem cells, cyclosporine, fludarabine)
Completed
- Mycosis Fungoides
- Sezary Syndrome
- A matched peripheral donor stem cells
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 2, 2020
Relapsing Multiple Sclerosis, Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial in United
Recruiting
- Relapsing Multiple Sclerosis
- +2 more
- Autologous Hematopoietic Stem Cell Transplantation
- Best Available Therapy (BAT)
-
Palo Alto, California
- +20 more
Jan 25, 2023
Kidney Transplantation Trial in United Kingdom (Alemtuzumab, Basiliximab, Sirolimus)
Completed
- Kidney Transplantation
- Alemtuzumab
- +3 more
-
Oxford, Oxon, United Kingdom
- +19 more
Mar 23, 2020
B-cell Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia, Stage 0 Chronic Lymphocytic Leukemia Trial in
Completed
- B-cell Chronic Lymphocytic Leukemia
- +4 more
- alemtuzumab
- +9 more
-
Rochester, MinnesotaMayo Clinic
Jun 11, 2020
Acute Lymphoblastic Leukemia Trial in La Jolla, San Diego (Alemtuzumab, Clofarabine)
Terminated
- Acute Lymphoblastic Leukemia
- Alemtuzumab
- Clofarabine
-
La Jolla, California
- +2 more
Jul 29, 2020
Sickle Cell Disease, Hemoglobin SC Trial in Houston (Busulfan, Campath 1H, Cyclophosphamide and MESNA)
Immunodeficiency Syndrome, Non-Cancer Diagnosis Trial in United States (biological, procedure, drug, other, radiation)
Completed
- Immunodeficiency Syndrome
- Non-Cancer Diagnosis
- Alemtuzumab
- +7 more
-
Oakland, California
- +5 more
Feb 5, 2020
